Displaying 11–20 of 275 research results
Jun 20, 2022
The newly approved drug reduces the pathologic hunger associated with BBS
Jun 13, 2022
In its seventh year, the Retinal Cell & Gene Therapy Innovation Summit featured 34 presentations from industry experts from around the world.
May 24, 2022
The company’s RPESC-RPE cell product is composed of progenitor-stage RPE cells grown from human eyes donated to eye banks.
May 19, 2022
However, the Phase 2/3 Illuminate trial for sepofarsen didn’t meet its endpoints at 12 months
May 17, 2022
The three-month results support the planned launch of the company’s Phase 2/3 Vista trial
May 13, 2022
The device is designed for people with late-stage AMD who have no treatment options
May 9, 2022
Editas is planning IND-enabling studies of the two-part treatment in preparation for a clinical trial
May 6, 2022
The study is an important step toward a clinical trial of the approach
May 2, 2022
The company is also conducting a Phase 3 clinical trial of the emerging therapy for geographic atrophy.
Apr 25, 2022
The Foundation Fighting Blindness recently held a webinar to provide details about an upcoming Externally-Led Patient Focused Drug Development (EL-PFDD) meeting for XLRP, and to provide background information about the Food and Drug Administration’s (FDA) drug review process.